Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20041
20052
20062
20071
20081
20104
20114
20122
20142
20151
20185
20191
20202
20216
20226
20236
20246
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated14
Active, not recruiting13
Recruiting9
Enrolling by invitation3
Withdrawn3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
UCB Pharma6
Novartis Pharmaceuticals5
AstraZeneca4
Viatris Innovation GmbH4
Biogen3
EMD Serono Research & Development Institute, Inc.3
Genelabs Technologies3
Human Genome Sciences Inc., a GSK Company3
NYU Langone Health3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic67
Autoimmune Diseases14
Immune System Diseases10
Connective Tissue Diseases9
Lupus Nephritis8
Lupus Erythematosus, Cutaneous3
Lupus Erythematosus, Discoid3
Nephritis3
Bone Diseases, Metabolic2
Arthritis, Juvenile1

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.